BIOTECH: Sorrento Mesa Firm Cites Growing Demand for its Products
Maravai LifeSciences has announced plans to expand the contract development and manufacturing organization (CDMO) capabilities at one of its companies, TriLink BioTechnologies, for the second time in less than a year.
BIOTECH: Allele Biotechnology Using Nanoantibodies from Llamas
Dr. Jiwu Wang was thinking ahead when he purchased a plot of land in Fallbrook to raise llamas about 12 years ago.
AGRICULTURE: New Investment Again Comes from Ospraie Ag Science
The agriculture-tech sector is growing and Agragene Inc. is attracting attention from investors.
BIOTECH: Boston Co. Was Spun Out of Ionis, Had IPO in 2017
Ionis Pharmaceuticals plans to acquire the remaining stake in Akcea Therapeutics that it does not already own for approximately $500 million cash.
BIOTECH: Company Received $4.2M in Grant Funding
San Diego-based Aegis Life, a biotechnology company developing vaccines and therapies for life-threatening diseases, has entered the race to combat COVID-19 with its DNA vaccine.
BIOTECH: Erasca Raises $236 Million
Erasca, a cancer therapeutics company seeking to eliminate cancer, has completed a $36 million extension of its Series B financing round, bringing its total Series B round to $236 million.
BIOTECH: Investigations to Focus on Understudied Part of Antibody
The National Institute of Allergy and Infectious Diseases, one of the National Institutes of Health, has awarded more than $6.4 million to Erica Ollmann Saphire, Ph.D., a professor at the La Jolla Institute for Immunology, to support research toward COVID-19 antibody therapeutics. The local organization announced the award on Aug. 20.
BIOTECH: Firm Uses Protein Engineering to Develop Drug Candidates
Inhibrx Inc. completed its initial public offering on Aug. 20, gaining an estimated $125.7 million to push its business forward.
On Wednesday, Aug. 26, 2020, several San Ysidro Health rural clinics in East County received a donation of meals for the organization’s front line staff from Frontline Foods as a thank you for their fearless dedication during this pandemic.
Diomics, a San Diego-based biotech company, announced on Aug. 19 that it is developing the Diocheck Antibody Indicator, which provides a simple way for individuals to monitor for the presence of antibodies to SARS-CoV-2 over an extended period of time.
TECH: Designs, Manufactures Healthcare Supply Chain Solutions
HEALTHCARE: Facility Designed to Give Members ‘Positive Experience’
INVESTMENT: Firm Aims to Deploy Capital to Life Science Companies